Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Sees Signs Of Post-Pandemic Recovery In Q2

Jul 17 2020

• By Reed Miller

• Source: shutterstock.com

Related Content

COVID-19: FDA’s Stenzel Talks Abbott Test, Future Clearances In Call

May 22 2020

ADA 2020: Abbott Expects CGM To Reduce Insulin Needed For Type 2 Diabetes

Jun 19 2020

Antibody Testing During And After The Pandemic: Not All Tests Are Created Equal

Jun 12 2020

Abbott Stays Ahead Of Edwards In Transcatheter Mitral Valve Race With Tendyne CE Mark

Jan 31 2020

Abbott’s Device And Diagnostics Businesses Maintain Growth Momentum In Q1

Apr 17 2020

FDA Clears Medtronic's And Boston Scientific's Remote Cardiac Monitors, Approves Abbott’s Bluetooth-Compatible ICDs

Jul 08 2020

CMS Proposes Coverage Policy For Transcatheter Edge-to-Edge Mitral Valve Repair

Jul 01 2020

Edwards, Abbott Settle Mitral Repair Patent Cases

Jul 15 2020

Related Companies

Abbott

Additional Topics

Sales & Earnings Companies Commercial Cardiovascular Cardiology Diagnostic Imaging Diagnostics In Vitro Diagnostics Medical Device

More from Business

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window